4Scheen AJ,Kulbertus H.Clinical study of the momth.Reveral and Prove-it:confirmation of the concept "the lower,the better" for cholesterol therapy in patients with coronary heart disease[J].Rev Med Liege,2004,59(3):167-173.
5Barter P.HDL:a recipe for longevity[J].Atheroscler Suppl,2004,5(2):25-31.
6Ray JG,Gong Y,Sykora K,et al.Statin Use and Survival Outtcomes in Elderly Patients With Heart Failure[J].Arch Intem Med,2005,165:62-67.
7Gupta EK,Ito MK.Lovastatin and extended-release niacin combination product:the first drug combination for the management of hyperlipidemia[J].Heart Dis,2002,4(2):124-137.
8Pieper JA.Overview of niacin formulations:differences in pharmacckimetics,efficacy,and safety[J].Am J Health Syst Pharm,2003,60(13 SuppI2):S9-14
9Grundy SM,Cleeman JI,Merz CN,et al.National Heart,Lung,and Blood Institute; American College of Cardiology Foundation; American Heart AssoCiation.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ[J].Circulation,2004,110(2):227-239.
10[1]Dohi Y,Hahn AW,Boulanger CM,et al.Endothelin stimulated by angiotensin Ⅱ augments contractivity of spontaneously hypertensive rat resistance arteries[J].Hypertension,1992,19(2):131-137.
